Synergistic effects were observed between NMD14, an NMD inhibitor, and G418 in inducing the expression of p53 target genes CDKN1A, BAX, and PUMA of human cancer cells harboring p53 nonsense mutations [69]. Here, TP53 is linked to cancer.